Yes, Viral Infections Can Cause Elevated CK Levels
Viral infections, including influenza and COVID-19, are well-documented causes of elevated creatine kinase (CK) levels, and this elevation can occur even without prominent muscle symptoms. The mechanism involves direct viral effects on muscle tissue, rhabdomyolysis, and metabolic dysfunction rather than classic inflammatory myopathy.
Evidence from Viral Infections
COVID-19 and CK Elevation
Multiple studies demonstrate that elevated CK is common in COVID-19 and carries prognostic significance:
- Prevalence: Approximately 18-46% of hospitalized COVID-19 patients develop elevated CK levels 1, 2
- Clinical significance: Elevated CK independently predicts severe outcomes including need for mechanical ventilation, ICU admission, and death, even when adjusting for inflammatory markers like CRP 1, 3
- Threshold: CK levels >200 U/L are associated with worse prognosis 3
- Pattern: The elevation is typically transient, returning to normal during hospitalization in most patients 3
Influenza and CK Elevation
Seasonal influenza also causes CK elevation with clinical consequences:
- AKI association: Even modest CK elevation (>186 U/L) at admission is significantly associated with development of acute kidney injury in influenza patients 4
- Severity correlation: Higher CK levels correlate with disease severity 4
- Histological findings: Muscle biopsies show metabolic dysfunction rather than inflammatory myopathy, with histochemical alterations suggesting metabolic disturbances 5
Key Clinical Disconnect
Important caveat: There is often no correlation between elevated CK levels and muscle symptoms (myalgia, weakness) 1, 2. Patients can have significantly elevated CK without reporting muscle pain or weakness, making CK elevation an independent laboratory finding rather than a symptom-driven diagnosis.
Mechanism of CK Elevation
The guidelines and research indicate viral infections cause CK elevation through:
- Direct viral-mediated muscle injury - not classic inflammatory myopathy 6
- Rhabdomyolysis - listed as a recognized cause of acute kidney injury in COVID-19 6
- Metabolic dysfunction - histochemical abnormalities suggesting metabolic disturbances rather than inflammation 5
- Multi-organ failure effects - systemic illness contributing to muscle breakdown 6
Clinical Recommendations
Based on guideline evidence 7:
When to check CK in viral infections:
- Patients admitted to hospital with influenza-like illness
- If myositis is suspected (though symptoms may be absent)
- As part of assessment for patients with severe viral illness
What to monitor:
- Serial CK measurements if initially elevated
- Renal function (creatinine, electrolytes) given association with acute kidney injury 4
- Liver function tests 7
- Full blood count 7
Clinical significance:
- CK >186 U/L in influenza predicts AKI development 4
- CK >200 U/L in COVID-19 predicts severe outcomes 3
- Extreme elevations (>100,000 U/L) can occur with viral infections, particularly when complicated by rhabdomyolysis 8
Practical Pitfalls
- Don't wait for muscle symptoms: CK can be markedly elevated without myalgia or weakness 1, 2
- Don't assume inflammatory myopathy: Muscle biopsies typically show metabolic dysfunction, not inflammation 5
- Monitor for complications: Elevated CK increases risk of acute kidney injury requiring aggressive fluid management 4
- Consider rhabdomyolysis: Particularly in severe cases with volume depletion and multi-organ involvement 6